An observational study in Diabetes (DM), sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-16.
Sponsored by Consorci Sanitari de l'Alt Penedès i Garraf · Observational
The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.
Patients affected by diabetes mellitus type 2
Exclusion Criteria:
These patients received joint care from a nurse and an endocrinologist in the day hospital before 2024.
Other: Day Care Hospital
These patients received joint care from a nutriotinist and finally an endocrinologist in ambulatory care unit after 2024.
Other: Nutritionist
Clinical follow-up under the joint care of a nurse and an endocrinologist at Day Care Hospital
Clinical follow-up with a dietitian-nutritionist and an endocrinologist at ambulatory care unit
Glycate hemoglobin
Glycated hemoglobin (HbA1c) levels three months after completion of the intervention
Time frame: three months after completion of the intervention
Plan to share: Yes — IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).
Supporting information: Study protocol
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Consorci Sanitari de l'Alt Penedès i Garraf